Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The MAGIC Algorithm Probability Guided Preemption of Steroid-refractory Graft-versus-host Disease With Ruxolitinib

NCT06075225 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT06075225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06075225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The MAGIC Algorithm Probability Guided Preemption of Steroid-refractory Graft-versus-host Disease With Ruxolitinib
Lead sponsor
Sichuan University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 1, 2023
Completion date
September 30, 2026
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute stem cell transplant complications, gvhd